Cargando…
Breast Cancer Resistance Mechanisms: Challenges to Immunotherapy
The clinical implementation of immunotherapy has profoundly transformed cancer treatment. Targeting the immune system to mount anti-tumor responses can elicit a systemically durable response. Employing immune checkpoint blockade (ICB) has suppressed tumor growth and vastly improved patient overall a...
Autores principales: | Hanna, Ann, Balko, Justin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560575/ https://www.ncbi.nlm.nih.gov/pubmed/34322780 http://dx.doi.org/10.1007/s10549-021-06337-x |
Ejemplares similares
-
Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
por: Taylor, Brandie C., et al.
Publicado: (2022) -
Pharmacological Activation of cGAS for Cancer Immunotherapy
por: Garland, Kyle M., et al.
Publicado: (2021) -
Future Challenges in Cancer Resistance to Immunotherapy
por: van Elsas, Marit J., et al.
Publicado: (2020) -
Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023) -
Therapeutic potential of DNA methyltransferase inhibitors with immune checkpoint inhibitor therapy in breast cancer
por: Luo, Na, et al.
Publicado: (2018)